News

Article March 25, 2026

Gladstone Expands Research Footprint With 105,000 Square Feet of New Laboratory Space

Gladstone Institutes is adding state-of-the-art laboratories in a newly constructed Mission Bay building.

History Institutional News News Release Genomic Immunology Data Science and Biotechnology Marson Lab Pollard Lab AI CRISPR/Gene Editing Genomics

Gladstone in the News March 25, 2026

Exclusive: Biotech Group Leases 105,000 Square Feet in S.F. as it Plans to Hire 300 Scientists

San Francisco Chronicle—In one of the city’s biggest leases of 2026 so far, Gladstone Institutes has secured 105,000 square feet in the last major new building of San Francisco’s Mission Bay, as part of its expansion plans that include hiring 300 new scientists. (Subscription required.)

Institutional News

Gladstone in the News March 23, 2026

Decoding the Tumor: Inside the AI-Driven Hunt for Colorectal Cancer Immunotherapy

Cancer Research Institute—Colorectal cancer is the second leading cause of cancer-related death in the U.S. But despite decades of progress, immunotherapy still falls short for the vast majority of patients with this cancer. Gladstone Investigator Karin Pelka is working to change that by listening in on the molecular conversations happening inside the tumor itself.

Gladstone Experts Cancer Genomic Immunology Pelka Lab

Article March 23, 2026

How AI Is Pinpointing the Genetic Cause of Disease

Scientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.

AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease

Video March 23, 2026

This Is AI Decoding the Genetic Cause of Disease

In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.

Gladstone Experts Pollard Lab Srivastava Lab AI

Video March 20, 2026

Science in Seconds | A New Path Toward Life Without Daily HIV Pills

In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.

Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan Lab

Article March 20, 2026

Why Some People Naturally Control HIV Even After Stopping Therapy—and How We Can Leverage That to Treat Others

New research offers a path toward life without daily HIV pills, suggesting common diabetes pill could help achieve long-term remission.

News Release Research (Publication) HIV/AIDS Infectious Disease Roan Lab

Gladstone in the News March 18, 2026

Brain’s Protective Barrier Stays Leaky for Years After Playing Contact Sports

Nature—Gladstone Investigator Katerina Akassoglou weighs in on a new study showing that long-lasting damage to the blood–brain barrier after repeated head trauma may drive chronic inflammation and cognitive decline.

Gladstone Experts Akassoglou Lab

Gladstone in the News March 18, 2026

Mitochondria Packaged in Blood Cell Membranes Improve Disease Symptoms in Mice

Science—Gladstone Investigator Ken Nakamura comments on a new study testing a method to deliver healthy mitochondria into cells. (Subscription required.)

Gladstone Experts Nakamura Lab

Gladstone in the News March 18, 2026

Scientists Create Cancer-Fighting Immune Cells Right in the Body

UCSF News—Gladstone Affiliate Investigator Justin Eyquem and his collaborators at Gladstone and UCSF demonstrated a new method to engineer CAR T cells directly inside the body, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

Gladstone Experts Cancer Genomic Immunology Eyquem Lab

Article March 18, 2026

Meet Gladstone: Kim Dam

From Wisconsin to Gladstone, Kim Dam is helping engineer a next-generation vaccine platform designed to tackle some of the world’s most challenging infectious diseases.

Profile Infectious Disease

Gladstone in the News March 10, 2026

Blood Money: This SF Startup is Paying Women for Their Monthly Flow

The San Francisco Standard—Deepak Srivastava offers perspective on the emerging use of mesenchymal stem-cells and the questions that remain about their therapeutic value.

Gladstone Experts Srivastava Lab

Gladstone in the News March 9, 2026

The Healthtech Playbook: 15 Innovators on How They Are Transforming Medical Care

Authority Magazine—Gladstone President Deepak Srivastava is recognized as one of 15 innovators helping shape the future of medical technology.

Gladstone Experts Srivastava Lab

Gladstone in the News March 4, 2026

New Tool Reveals the Secrets of HIV-Infected Cells

The Microbiologist—Gladstone Investigator Nadia Roan and her team have developed a novel tool, named HIV-seq, for profiling the features of rare HIV-infected cells from people with HIV.

Gladstone Experts HIV/AIDS Infectious Disease Roan Lab

Article March 3, 2026

Virologist Viewpoints: For HIV, ‘Manageable’ Is No Longer Good Enough

Once a godsend, antiretroviral therapy is not what we should settle on. The time has come to finally cure HIV/AIDS.

HIV/AIDS Ott Lab